Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by steadfaston May 17, 2022 2:01pm
186 Views
Post# 34689807

MESSAGE TO SERNOVA'S INVESTORS RELATIONS TEAM

MESSAGE TO SERNOVA'S INVESTORS RELATIONS TEAM
SVA HAS A CHART that looks really good technically.  You have been given a gift with
to-day's annct on the Science, your responsibility for each day this week is to ensure
SVA closes above $1.60 to allow the Fibonacci extension to come into play, it would target
$3.75 as a Minimum next move.  Time to see some ACTION FROM YOU WITHIN THE
NEXT 2 HOURS AND THROUGHOUT THE WEEK AND WEEKS TO COME.  DO YOU
DO YOUR HOMEWORK ON FIBONNACI???? SVA has been building a base, now is the
time for you to ensure the bigger move comes into play. 

I would hope we will read lots of Press Releases later today and over the next few days
that I am sure you have well organized, if you haven't, I would sugggest you alert the
World SVA has the only patient in the World insulin independent for over 2 years.
ViaCyte & Vertext seem able to capture the attention of the press, it is Sernova's turn.
<< Previous
Bullboard Posts
Next >>